Eubel Brady & Suttman Asset Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-110
Closed -$20K – 309
2021
Q2
$20K Buy
+110
New +$17.8K ﹤0.01% 464

Other funds holding TDOC

Eubel Brady & Suttman Asset Management's TDOC Position: Q3 2021 in Review

Eubel Brady & Suttman Asset Management sold out of Teladoc Health (TDOC) in Q3 2021, closing a stake of 110 shares — an estimated $20K sold.

Eubel Brady & Suttman Asset Management first reported a position in TDOC in Q2 2021 and held it in 1 quarter. The position peaked at $20K in Q2 2021. 761 funds tracked by Wall St. Rank hold TDOC as of Q3 2021.

  • Eubel Brady & Suttman Asset Management reported no remaining Teladoc Health position as of Q3 2021 after selling out during the quarter.
  • Eubel Brady & Suttman Asset Management sold 110 Teladoc Health shares in Q3 2021, an estimated $20K.
  • Eubel Brady & Suttman Asset Management first reported a position in Teladoc Health in Q2 2021 and held it in 1 quarter.
  • Eubel Brady & Suttman Asset Management's Teladoc Health position peaked at $20K in Q2 2021.
  • 761 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2021.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.